SOURCED REPORTING · 2026-11-01
Barbados earns WHO recognition for preventing HIV transmission to babies
2022–2024 · %
Barbados, 2022–2024. Antenatal care and testing: pregnant women. Treatment: pregnant women living with HIV. Separate populations; no linked cohort or headcounts supplied.
Barbados · WHO recognition October 30, 2026; assessment 2022–2024. Infant HIV transmission, not HIV eradication.
WHO announced Barbados’s certification October 30, citing no reported mother-to-child infant HIV infections in 2022–2024 and high care coverage. The achievement depends on continued testing, treatment and follow-up; HIV has not disappeared. [1] [2] [6]
Photo context & credit
Archive photograph · 2007-07 · Bridgetown, Barbados

- 1 source record
- World Health Organization
How we know6 scoped claims · 1 source recordView evidence
Each claim keeps its full assertion, date, source passage and limits. Source counts describe records, not independent corroboration.
1.Recognition announced October 30Attributed
WHO announced that Barbados had achieved elimination of mother-to-child HIV transmission as a public-health problem.
- Scope
- Barbados · WHO recognition October 30, 2026; assessment 2022–2024. Infant HIV transmission, not HIV eradication.
- Evidence passage
- Headline and opening paragraph; certification paragraph beginning Certification by WHO follows.
- As of
- 2026-11-01
- Limit
- WHO reports an independent assessment; NTDS has not obtained the full assessment or audited patient records.
Retrieved 2026-11-01T13:44:45.352Z · World Health Organization
WHO’s institutional account of an assessment; underlying patient and validation records not available here.
2.Surveillance period: 2022–2024Attributed
WHO says no new infant HIV infections from mother-to-child transmission were reported in Barbados during 2022–2024.
- Scope
- Barbados · WHO recognition October 30, 2026; assessment 2022–2024. Infant HIV transmission, not HIV eradication.
- Evidence passage
- Paragraph beginning Certification by WHO follows; sentence beginning From 2022 to 2024.
- As of
- 2026-11-01
- Limit
- Reported surveillance outcome for a dated period; no national HIV-eradication or future-zero claim.
Retrieved 2026-11-01T13:44:45.352Z · World Health Organization
WHO’s institutional account of an assessment; underlying patient and validation records not available here.
3.Antenatal care among pregnant womenAttributed
WHO reports 98% antenatal-care coverage among pregnant women in the three-year assessment period.
- Scope
- Barbados · WHO recognition October 30, 2026; assessment 2022–2024. Infant HIV transmission, not HIV eradication.
- Evidence passage
- Paragraph beginning The assessment found consistently high coverage.
- As of
- 2026-11-01
- Limit
- Denominator is pregnant women, not births or women living with HIV. No headcount or uncertainty interval supplied.
Retrieved 2026-11-01T13:44:45.352Z · World Health Organization
WHO’s institutional account of an assessment; underlying patient and validation records not available here.
4.HIV testing among pregnant womenAttributed
WHO reports that 98% of pregnant women were tested for HIV during the assessment period.
- Scope
- Barbados · WHO recognition October 30, 2026; assessment 2022–2024. Infant HIV transmission, not HIV eradication.
- Evidence passage
- The assessment found paragraph, second coverage measure.
- As of
- 2026-11-01
- Limit
- Denominator is pregnant women. Equal percentages do not establish that the same women were tracked through every service.
Retrieved 2026-11-01T13:44:45.352Z · World Health Organization
WHO’s institutional account of an assessment; underlying patient and validation records not available here.
5.Treatment among pregnant women living with HIVAttributed
WHO reports antiretroviral treatment for 98% of pregnant women living with HIV during the assessment period.
- Scope
- Barbados · WHO recognition October 30, 2026; assessment 2022–2024. Infant HIV transmission, not HIV eradication.
- Evidence passage
- The assessment found paragraph, third coverage measure.
- As of
- 2026-11-01
- Limit
- Different denominator: pregnant women living with HIV. Do not combine the three percentages into a funnel.
Retrieved 2026-11-01T13:44:45.352Z · World Health Organization
WHO’s institutional account of an assessment; underlying patient and validation records not available here.
6.Care must continueAttributed
WHO describes voluntary confidential testing, free testing and treatment for pregnant women regardless of nationality, infant follow-up and continued investment needed to maintain elimination status.
- Scope
- Barbados · WHO recognition October 30, 2026; assessment 2022–2024. Infant HIV transmission, not HIV eradication.
- Evidence passage
- Editor’s note; paragraphs beginning Barbados provides universal health care and To maintain elimination status.
- As of
- 2026-11-01
- Limit
- Institutional account; clinic opening hours, appointment availability and individual eligibility beyond the stated service scope are not independently established.
Retrieved 2026-11-01T13:44:45.352Z · World Health Organization
WHO’s institutional account of an assessment; underlying patient and validation records not available here.
Still open: Underlying independent validation report and case-level surveillance were not obtained.
What remains unresolved
- Underlying independent validation report and case-level surveillance were not obtained.
- Coverage headcounts, uncertainty intervals and a linked patient cohort are unavailable.
- The official Barbados directory was fetched and visibly read as practical help only; current appointments, hours and service delivery were not tested.
A correction to the identified original record, a materially changed official status, or new primary evidence resolving the listed gaps would reopen these exact claims and their dependent narrative and visual.




